Blood Ther Med. 2002; 3: 21- 6.
72. Fennis JP, Stoelinga PJ, Jansen JA. Mandibular reconstruction: a histological and histomorphometric study on the use of autogenous scaffolds, particulate cortico- cancellous bone grafts and platelet rich plasma in goats. Int J Oral Maxillofac Surg. 2004 ; 33: 48- 55.
73. Kasten P, Vogel J, Luginbühl R, Niemeyer P, Weiss S, Schneider S, Kramer M, Leo A, Richter W. Influence of platelet- rich plasma on osteogenic differantiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs. 2006; 183: 68- 79.
74. Schlegel KA, Donath K, Rupprecht S, Falk S, Zimmermann R, Felszeghy E, Wiltfang J. De novo bone formation using bovine collagen and platelet- rich plasma. Biomaterials.
2004; 25: 5387- 93.
75.Melgaard L, Hersini KJ, Gazerani P, Petersen LJ. Retrodialysis: A Review of Experimental and Clinical Applications of Reverse Microdialysis in the Skin. Skin Pharmacol Physiol 2013; 26: 160-174.
54
76. Sørensen MA,Jacobsen S,Petersen LJ.Microdialysis in equine research: a review of clinical and experimental findings.Vet J. 2013;197:553-559.
77. Bursa F, Olos T, Pleva L, Kula R, Jahoda J, Procházka V, Kopácek I.Metabolism monitoring with microdialysis in the intensive care. Cas Lek Cesk. 2011;150:605-609.
78. Larach DB , Kofke WA , Le Roux P .Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature.
Neurocrit Care. 2011; 15: 609-22.
79. .Frasca D, Dahyot-Fizelier C, Adier C, Mimoz O, Debaene B, Couet W, Marchand S.
Microdialysis assessment of brain extracellular fluid concentrations in patients with acute brain injury.Antimicrob Agents Chemother. 2013; 25.
80. Jacus MO, Throm SL, Turner DC, Patel YT, Freeman BB, Morfouace M, Boulos N, Stewart CF. Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data. Eur J Pharm Sci.
2013; 20.
81. Thomas DW, O’Neill ID, Harding KG, et al. Cutaneous wound healing: a current perspective. J Oral Maxillofac Surg 1995; 53: 442-447.
82. Folkman J, Shing T. Angiogenesis. J Biol Chem 1992; 267: 10931- 10934.
83. Madri JA, Sankar S, Romanic AM. Angiogenesis. In: Clark RAF (ed). The Molacular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996;
355- 372.
84. Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: 228-31.
85. Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for failure in patients with septic shock. Crit Care Med 2001; 29:
385- 91.
86. Brunner M, Pernerstorfer T, Mayer BX, et al. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med 2000; 28: 1754-9.
87. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986; 11: 470-82.
88. Stahle L, Arner P, Ungerstedt U. Drug distribution studies with microdialysis: III.
Extracellular concentration of caffeine in adipose tissue in man. Life Sci 1991; 49: 1853-1858.
89. Lonnroth P. Microdialysis: a new and promising method in clinical medicine. J Intern Med 1991; 230: 363-364
90. Muller M, Schmid R, Georgopoulos A, et al. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995; 57: 371-380.
91. Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 1994; 102: 807-11.
92. Hickner RC, Ekelund U, Mellander S, et al. Muscle blood flow in cats: comparison of microdialysis ethanol technique with direct measurement. J Appl Physiol 1995; 79: 638-647.
93. Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Robey PG. İn vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape.
Biotechnol Bioeng. 2001; 72: 96-107.
94. Frechette JP, Martineau I, Gagnon G. Platelet- rich plasmas: growth factor content and roles in wound healing. J Dent Res. 2005; 84: 434-439.
95. Oyama T, Nishimoto S, Tsugawa T, Shimizu F. Efficacy of platelet- rich plasma in alveolar bone grafting. J Oral Maxillofac Surg. 2004; 62: 555-558.
56
96. Roldan JC, Jepsen S, Miller J, Freitag S, Rueger DC, Açil Y, Terheyden H. Bone formation in the presence of platelet- rich plasma vs. bone morphogenetic protein- 7. Bone.
2004;34: 80-90.
97. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet- rich plasma:
tissue engineered bone regeneration. Tissue Eng. 2004; 10; 955-64.
98. Mooar, P. A., Gardner, M. J., Klepchick, P. R., and Sherk, H. H. The efficacy of autologous platelet gel on total knee arthroplasty: An analysis of range of motion, hemoglobin, and narcotic requirement. Presented at the 67th Annual Meeting of the American Association of Orthopedic Surgeons, Orlando, Fla 2000;15.
99. Whitman, D. H., Berry, R. L., and Green, D. M. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J. OralMaxillofac. Surg.
1997;55: 1294.
100. Marx, R. E., Carlson, E. R., Eichstaedt, R. M., et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. J. Oral Maxillofac. Surg 1998;85: 638.
101. Kim, S., Chung, C., Kim, Y., Park, J., and Lim, S. Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int. J. Oral Maxillofac. Implants 2002;17: 86.
102. Margolis, D. J., Kantor, J., Santanna, J., Strom, B. L., and bBerlin, J. A. Effectiveness of platelet releasate for treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24: 483.
103. Welsh, W. J. Autologous platelet gel: Clinical function and usage in plastic surgery.
Cosmet. Dermatol 2000;13: 51.
104. Bhanot, S., and Alex, J. C. Current applications of platelet gels in facial plastic surgery. Facial Plast. Surg 2002;18:27.
105. Barry L. Eppley, M.D., D.M.D., Jennifer E. Woodell, Ph.D., and Joel Higgins, B.S.
Platelet Quantification and Growth Factor Analysis from Platelet-Rich Plasma:
Implications for Wound Healing. Plastic and Reconstructive Surgery 2004;114:6.
106. Keswani SG, Katz AB, Lim FY, et al. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen.
2004;12:497-504.
107. Steed DL. Modifying the wound healing response with exogenous growthfactors. Clin Plast Surg. 1998;25:397-405.
108. Tsang MW, Wong WK, Hung CS, et al. Human epidermal growth factorenhances healing of diabetic foot ulcers. Diabetes Care. 2003;26:1856-1861.
109. Embil JM, Papp K, Sibbald G, et al. Recombinant human platelet-derivedgrowth factor-BB (becaplermin) for healing chronic lower extremity diabeticulcers: an open-label clinical evaluation of efficacy. Wound Repair Regen.2000;8:162-168.
110. Vooijs DP, Walboomers XF, Parker JA, et al. Transforming growth factorbeta3-loaded microtextured membranes for skin regeneration in dermal wounds.J Biomed Mater Res A. 2004;70:402-411.
111.Gentile P, Di Pasquali C, Bocchini I, Floris M, Eleonora T, Fiaschetti V, Floris R and Cervelli V. Breast Reconstruction With Autologous Fat Graft Mixed With Platelet-Rich Plasma. Surg Innov 2012.
112.Aggeliki Zografou, Othon Papadopoulos, Christos Tsigris, Nikolaos Kavantzas, Efstathios Michalopoulos, Theofanis Chatzistamatiou, Andreas Papassavas, Catherine Stavropoulou-Gioka, Ismini Dontas, and Despoina PerreaAutologous Transplantation of Adipose-Derived Stem CellsEnhances Skin Graft Survival and Wound Healing in Diabetic Rats. Ann Plast Surg 2013;71: 225-232
113. Medina A, Scott PG, Ghahary A, et al. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil. 2005;26:306-319.